<font><font face="trebuchet ms,sans-serif">[Forwarding from the British Library. --Peter Suber.]<br></font></font><br><div class="gmail_quote"><br>
<div>
<div dir="ltr" align="left">
<div><font face="Arial"><span></span></font></div><font face="Arial"><span><span style="font-family:Syntax"><font>PRESS
RELEASE<br>12 January 2010</font></span></span></font></div>
<div>
<p class="MsoNormal" style="margin:0cm 0cm 0pt"><b><span style="font-family:Syntax"><font> </font></span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><b><span style="line-height: 130%; font-family: Syntax; ">Innovative new
web interface improves access to UK’s largest free online life
sciences resource - </span></b><b><span style="color: navy; line-height: 130%; font-family: Syntax; "><a title="http://beta.ukpmc.ac.uk/" href="http://beta.ukpmc.ac.uk/" target="_blank">http://beta.ukpmc.ac.uk/</a></span></b><b><span style="line-height: 130%; font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><b><span style="font-family:Syntax"><font> </font></span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><font><b><span style="font-family:Syntax">Helping researchers access and exploit over 1.7
million full-text, peer reviewed biomedical research articles and over 19
million other life science research papers, on 12 January the British Library
will showcase a whole range of new search and data mining tools designed to
unlock the scientific knowledge held by UK PubMed
Central.<br><br></span></b><span style="font-family:Syntax">Developed in direct
consultation with researchers, UK PubMed Central (UKPMC) aims to become the
information resource of choice for the UK biomedical and health research
community. <span> </span>Launched by <b>Professor Dame Sally C Davies</b>, Director
General, Research and Development at the Department of Health, the Open Beta
version of UKPMC will enable researchers to search and link information from
literature and drill down into underlying datasets in new and innovative ways.<b></b></span></font></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font> </font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font>Supported by the UK’s eight principal
funders of biomedical and health research, who fund over 90% of the country’s
research publications in the field, UKPMC offers users a comprehensive and
sustainable repository for UK funded free-to-access life sciences research.
Developed in collaboration with the founders of PubMed Central in the US, the
National Centre for Biotechnology Information (NCBI), the consolidation of
published research outputs into globally accessible resources such as UKPMC is
not only vital for widening access to knowledge and improving the efficiency of
desk research, but it will also vastly improve the ability of funding
organisations to assess the impact of their research, and help to better inform
scientific strategy and policy making. </font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font> </font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><font><span style="font-family:Syntax">The showcase event will provide the
chance to try out some of the new features that have been developed by the
British Library and the consortium of programme partners including European
Bioinformatics Institute, Mimas at the University of Manchester and the National Centre for
Text Mining. <span> </span>There will also be the
opportunity to hear from some of the key funders behind the programme, including
<b>Professor Doug Kell, </b>Chief Executive
of the </span><span style="font-family:Syntax">Biotechnology and
Biological Sciences Research Council</span><span style="font-family:Syntax">,
and <b>Sir Mark Walport</b>, Director of
the Wellcome Trust, on the value and importance of UKPMC for the research
community. </span></font></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font> </font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font>The easy-to-use, intuitive interface
developed by the British Library for the latest Beta version will enable
researchers to:</font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font> </font></span></p>
<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font>Conduct a full-text search of 1.7
million articles </font></span>
</li><li class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font>Access abstracts for over 19 million
articles</font></span>
</li><li class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><span style="font-family:Syntax"><font>Exploit the scientific literature
with innovative features which enrich abstracts and full-text articles by
linking scientific terms to other sources of quality assured and useful
information</font></span></li></ul>
<p class="MsoNormal" style="margin:0cm 0cm 0pt 36pt;line-height:130%"><span style="font-family:Symbol"><span><font>·</font><span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><font><span style="font-family:Syntax">Search
content not included in traditional journal literature – including clinical
guidelines as well as other hard to find material such as PhD theses<br><br></span><span style="font-family:Arial"></span></font></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:130%"><b><span style="font-family:Syntax"><font>Professor
Dame Sally C Davies – Director General Research and Development Department of
Health, said: </font></span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt"><span style="font-family:Syntax"><font> </font></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt;line-height:132%"><font><i><span style="font-family:Syntax">“I am delighted that
UK PubMed Central is ready to launch
new features on its website. This technology will make it possible to discover
and use hidden ‘gems’ of information buried in the documents within
UK PubMed Central. The Funders’
commitment to Open Access, and to making research outputs available through UK
PubMed Central, means this advance will increase the knowledge base and allow
research to realise even greater health and economic benefits for this
country.”</span></i><i><span lang="EN" style="font-family:Syntax"></span></i></font></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm;line-height:130%"><b><span lang="EN" style="font-family:Syntax"><br><font>Richard
Boulderstone, the British Library’s Director of eStrategy, said:
</font></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm;line-height:130%"><i><span lang="EN" style="font-family:Syntax"><font>“With over 1.7
million full-text, free-to-access biomedical research articles and an ever
increasing archive of additional research content, such as PhD theses and
clinical guidelines, UK
PubMed Central is fast becoming the information resource of choice for the
UK’s biomedical and health research
community. Developed by the British Library through open consultation with a
wide range of researchers, the new data mining tools will allow users to really
interrogate the collection; informing research, reducing duplication of work,
and inspiring new scientific discovery.”<span>
</span></font></span></i></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm;line-height:130%"><strong><span lang="EN" style="font-family:Syntax"><font>For more
information and interviews please contact the British Library Press Office -
Jacob Lant </font><a href="mailto:jacob.lant@bl.uk" target="_blank"><span style="font-weight:normal"><font>jacob.lant@bl.uk</font></span></a><font> / +44(0)20 7412 7105 or Miki Lentin </font><a href="mailto:miki.lentin@bl.uk" target="_blank"><span style="font-weight:normal"><font>miki.lentin@bl.uk</font></span></a><font> / +44(0)20 7412
7112</font></span></strong><b><span lang="EN" style="font-family:Syntax"></span></b></p>
<h2 style="background:white;margin:0cm 0cm 7.5pt;line-height:16.8pt"><strong><span lang="EN" style="font-family: Syntax; "><font color="#514641"><span class="Apple-style-span" style="font-size: small;"> ---------- </span></font></span></strong></h2>
<h2 style="background:white;margin:0cm 0cm 7.5pt"><font color="#514641"><strong><span lang="EN" style="font-family: Syntax; "><span class="Apple-style-span" style="font-size: small;">Notes
for Editors</span></span></strong><span class="Apple-style-span" style="font-size: small;"><span lang="EN" style="font-family: Syntax; "></span></span></font></h2>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm"><strong><span lang="EN" style="font-family: Syntax; ">1.
UK PubMed
Central</span></strong><span lang="EN" style="font-family: Syntax; ">
(</span><span style="color: blue; font-family: Syntax; "><a title="http://ukpmc.ac.uk/" href="http://ukpmc.ac.uk/" target="_blank">http://ukpmc.ac.uk/</a></span><span lang="EN" style="font-family: Syntax; ">) is a
UK initiative of PubMed Central, the
free archive of life sciences journals developed by the National Institutes of
Health National Centre for Biotechnology Information (NCBI). NCBI is based at
the National Library of Medicine in the United States. Read more on PubMed
Central’s international initiative here:
<a href="http://www.pubmedcentral.nih.gov/about/pmci.html" target="_blank">http://www.pubmedcentral.nih.gov/about/pmci.html</a></span></p>
<p class="MsoNormal" style="background:white;margin:0cm 0cm 0pt"><strong><span lang="EN" style="font-family: Syntax; ">2.
UK PubMed Central
mission</span></strong><span lang="EN" style="font-family: Syntax; "> is to
become the information resource of choice for the UK biomedical
and health research community by: </span></p>
<p class="MsoNormal" style="background:white;margin:0cm 0cm 0pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><span lang="EN" style="font-family: Syntax; ">Establishing
and expanding a single sustainable repository for UK-funded research
outputs</span></p>
<p class="MsoNormal" style="background:white;margin:0cm 0cm 0pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><span lang="EN" style="font-family: Syntax; ">Developing
innovative tools to enable better and more effective use of the existing
content</span></p>
<p class="MsoNormal" style="background:white;margin:0cm 0cm 0pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><span lang="EN" style="font-family: Syntax; ">Providing
access to additional content that integrates seamlessly into the UK PubMed
Central web-site </span></p>
<p class="MsoNormal" style="background:white;margin:0cm 0cm 0pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><span lang="EN" style="font-family: Syntax; ">Creating
comprehensive analysis and reporting tools for researchers and funders to inform
strategy and policy making </span></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm"><strong><span lang="EN" style="font-family: Syntax; ">3.
UK PubMed Central is supported with
funding from: </span></strong></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span lang="EN" style="font-family: Syntax; ">The
Arthritis Research Campaign </span></b><span style="font-family: Syntax; ">is
the leading authority on arthritis in the UK, conducting
scientific and medical research into all types of arthritis and musculoskeletal
conditions. It is the UK’s
fourth largest medical research charity and the only charity solely committed to
funding high quality research into the cause, treatment and cure of arthritis,
which affects more than ten million people in the UK today and
millions more worldwide. We rely entirely on public donations to fund our
research and education programmes, and spend more than £30m a year in
universities and medical schools to support pioneering biomedical research in
order to improve the lives of people with arthritis.</span><b><span lang="EN" style="font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">The
Biotechnology and Biological Sciences Research Council</span></b><span style="font-family: Syntax; ">
(BBSRC) is the UK funding agency for research in the
life sciences. Sponsored by Government, BBSRC annually invests around £450M in a
wide range of research that makes a significant contribution to the quality of
life for UK citizens and supports a number of
important industrial stakeholders including the agriculture, food, chemical,
healthcare and pharmaceutical sectors. BBSRC carries out its mission by funding
internationally competitive research, providing training in the biosciences,
fostering opportunities for knowledge transfer and innovation and promoting
interaction with the public and other stakeholders on issues of scientific
interest in universities, centres and institutes.</span><b><span lang="EN" style="font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">British
Heart Foundation </span></b><span style="font-family: Syntax; ">is the nation’s heart charity,
dedicated to saving lives through pioneering research, patient care, campaigning
for change and by providing vital information. But we urgently need help. We
rely on donations of time and money to continue our life-saving work. Because
together we can beat heart disease.</span><b><span lang="EN" style="font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">Cancer
Research UK </span></b><span style="font-family: Syntax; ">i</span><span style="font-family: Syntax; ">s
the world’s leading charity dedicated to beating cancer through research.<span> </span>The charity’s groundbreaking work into
the prevention, diagnosis and treatment of cancer has helped save millions of
lives.<span> </span>This work is funded entirely
by the public.<span> </span>Cancer Research
UK has been at the heart of the
progress that has already seen survival rates double in the last thirty
years.<span> </span></span><span lang="EN" style="font-family: Syntax; ">Cancer
Research UK supports research into all aspects
of cancer through the work of more than 4,800 scientists, doctors and
nurses.</span><span style="font-family: Syntax; "><span> </span>T</span><span style="font-family: Syntax; ">ogether
with its partners and supporters, Cancer Research UK's vision is
to beat cancer.</span></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">Chief
Scientist Office </span></b><span style="font-family: Syntax; ">is
</span><span style="color: black; font-family: Syntax; ">part
of the Scottish Government Health Directorates, which supports and promotes high
quality research aimed at improving the quality and cost-effectiveness of
services offered by NHS Scotland and securing lasting improvements to the health
of the people of Scotland. CSO supports research
initiated by the research community in Scotland and advises the Scottish
Government on how research contributes to improvements in health and healthcare.
CSO's research strategy "Investing in Research: Improving Health" sets out our
aims for the next 5 years and features changes to give greater emphasis to
funding experimental and translational medicine research and health services and
health population research. CSO also aims to deliver value for money through
partnerships with other funding agencies and to foster Scotland-wide working
through the Scottish Academic health Services Collaboration.</span><b><span lang="EN" style="font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">Department
of Health - </span></b><span style="font-family: Syntax; ">Through
the National Institute for Health Research, the Department of Health supports
research in the NHS in England, with a budget of around
£900m in 2009/10. The development of the NIHR includes a series of measures
designed to transform the health research environment. See <a href="http://www.nihr.ac.uk/" target="_blank">www.nihr.ac.uk</a>. The NIHR’s mission is to
create a health research system in which the NHS supports outstanding
individuals working in world-class facilities, conducting leading-edge research,
focused on the needs of patients and the public. </span><b><span lang="EN" style="font-family: Syntax; "><br><br></span></b></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span style="color: black; font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><b><span style="font-family: Syntax; ">Medical
Research Council</span></b><span style="font-family: Syntax; ">
</span><span style="font-family: Syntax; ">For almost 100 years
the Medical Research Council has improved the health of people in the UK and
around the world by supporting the highest quality science. The MRC invests in
world-class scientists. It has produced 29 Nobel Prize winners and sustains a
flourishing environment for internationally recognised research. The MRC focuses
on making an impact and provides the financial muscle and scientific expertise
behind medical breakthroughs, including the first antibiotic penicillin, the
structure of DNA and the lethal link between smoking and cancer. Today MRC
funded scientists tackle research into the major health challenges of the 21st
century.<span><span style="color:black"> </span></span><a href="http://www.mrc.ac.uk/" target="_blank"><span style="color:#9a044b">www.mrc.ac.uk</span></a><span style="color:black"></span></span></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm 7.5pt 18pt"><span lang="EN" style="font-family: Symbol; "><span>·<span style="font:7pt 'Times New Roman'"><span class="Apple-style-span" style="font-size: small;">
</span></span></span></span><strong><span style="font-family: Syntax; ">The
Wellcome Trust</span></strong><span style="font-family: Syntax; "> is
the largest charity in the UK. It funds innovative biomedical
research, in the UK and internationally, spending over
£600 million each year to support the brightest scientists with the best ideas.
The Wellcome Trust supports public debate about biomedical research and its
impact on health and wellbeing. <a title="http://www.wellcome.ac.uk/" href="http://www.wellcome.ac.uk/" target="_blank"><span style="color:#606420">http://www.wellcome.ac.uk</span></a></span><span style="font-family: Syntax; "> </span><b><span lang="EN" style="font-family: Syntax; "></span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt"><font face="Times New Roman"> </font></p>
<p class="MsoNormal" style="margin:0cm 0cm 0pt"><strong><span lang="EN" style="font-family: Syntax; ">4. The
development partners for UK
PubMed Central are:</span></strong><span lang="EN" style="font-family: Syntax; "><br>The
British Library, Mimas and NaCTeM (National Centre for Text Mining) at the
University of
Manchester, the European
Bioinformatics Institute.</span></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm"><strong><span lang="EN" style="font-family: Syntax; ">5.
The British Library</span></strong><span lang="EN" style="font-family: Syntax; "> is the
national library of the United Kingdom and one of the world's
greatest research libraries. It provides world class information services to the
academic, business, research and scientific communities and offers unparalleled
access to the world's largest and most comprehensive research collection. The
Library's collection has developed over 250 years and exceeds 150 million
separate items representing every age of written civilisation. It includes:
books, journals, manuscripts, maps, stamps, music, patents, newspapers and sound
recordings in all written and spoken languages <u><span style="color:black"><a href="http://www.bl.uk/science" target="_blank">www.bl.uk/science</a></span></u>
</span></p>
<p class="MsoNormal" style="background:white;margin:7.5pt 0cm"><font class="Apple-style-span" face="Syntax"><br></font></p></div></div></div>